Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Scholar Rock Holding Corporation (SRRK) stock

Learn how to easily invest in Scholar Rock Holding Corporation stock.

Scholar Rock Holding Corporation
NASDAQ: SRRK - USD
BIOTECHNOLOGY
$0
-

Scholar Rock Holding Corporation is a biotechnology business based in the US. Scholar Rock Holding Corporation shares (SRRK) are listed on the NASDAQ and all prices are listed in US Dollars. Scholar Rock Holding Corporation employs 119 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Scholar Rock Holding Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SRRK – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Scholar Rock Holding Corporation stock price (NASDAQ: SRRK)

Use our graph to track the performance of SRRK stocks over time.

Scholar Rock Holding Corporation shares at a glance

Information last updated 2021-07-23.
Latest market close$26.87
52-week range$10.28 - $70.00
50-day moving average $29.76
200-day moving average $41.45
Wall St. target price$64.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.95

Buy Scholar Rock Holding Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Scholar Rock Holding Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Scholar Rock Holding Corporation price performance over time

Historical closes compared with the close of $26.87 from 2021-05-28

1 week (2021-07-16) N/A
1 month (2021-06-25) -11.09%
3 months (2021-04-27) -24.16%
6 months (2021-01-23) N/A
1 year (2020-07-23) N/A
2 years (2019-07-23) N/A
3 years (2018-07-23) N/A
5 years (2016-07-23) N/A

Scholar Rock Holding Corporation financials

Revenue TTM $15.1 million
Gross profit TTM $15.4 million
Return on assets TTM -22.47%
Return on equity TTM -57.25%
Profit margin 0%
Book value $6.99
Market capitalisation $1.1 billion

TTM: trailing 12 months

Shorting Scholar Rock Holding Corporation shares

There are currently 3.4 million Scholar Rock Holding Corporation shares held short by investors – that's known as Scholar Rock Holding Corporation's "short interest". This figure is 30.2% up from 2.6 million last month.

There are a few different ways that this level of interest in shorting Scholar Rock Holding Corporation shares can be evaluated.

Scholar Rock Holding Corporation's "short interest ratio" (SIR)

Scholar Rock Holding Corporation's "short interest ratio" (SIR) is the quantity of Scholar Rock Holding Corporation shares currently shorted divided by the average quantity of Scholar Rock Holding Corporation shares traded daily (recently around 294771.61234991). Scholar Rock Holding Corporation's SIR currently stands at 11.66. In other words for every 100,000 Scholar Rock Holding Corporation shares traded daily on the market, roughly 11660 shares are currently held short.

However Scholar Rock Holding Corporation's short interest can also be evaluated against the total number of Scholar Rock Holding Corporation shares, or, against the total number of tradable Scholar Rock Holding Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Scholar Rock Holding Corporation's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Scholar Rock Holding Corporation shares in existence, roughly 100 shares are currently held short) or 0.1475% of the tradable shares (for every 100,000 tradable Scholar Rock Holding Corporation shares, roughly 148 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Scholar Rock Holding Corporation.

Find out more about how you can short Scholar Rock Holding Corporation stock.

Scholar Rock Holding Corporation share dividends

We're not expecting Scholar Rock Holding Corporation to pay a dividend over the next 12 months.

Scholar Rock Holding Corporation share price volatility

Over the last 12 months, Scholar Rock Holding Corporation's shares have ranged in value from as little as $10.28 up to $70. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scholar Rock Holding Corporation's is 0.1006. This would suggest that Scholar Rock Holding Corporation's shares are less volatile than average (for this exchange).

Scholar Rock Holding Corporation overview

Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, a novel inhibitor of the activation of latent myostatin that has completed the Phase II clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase I clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. .

Stocks similar to Scholar Rock Holding Corporation

Scholar Rock Holding Corporation in the news

There are no recent company news

Frequently asked questions

What percentage of Scholar Rock Holding Corporation is owned by insiders or institutions?
Currently 3.957% of Scholar Rock Holding Corporation shares are held by insiders and 100.393% by institutions.
How many people work for Scholar Rock Holding Corporation?
Latest data suggests 119 work at Scholar Rock Holding Corporation.
When does the fiscal year end for Scholar Rock Holding Corporation?
Scholar Rock Holding Corporation's fiscal year ends in December.
Where is Scholar Rock Holding Corporation based?
Scholar Rock Holding Corporation's address is: 301 Binney Street, Cambridge, MA, United States, 02142
What is Scholar Rock Holding Corporation's ISIN number?
Scholar Rock Holding Corporation's international securities identification number is: US80706P1030
What is Scholar Rock Holding Corporation's CUSIP number?
Scholar Rock Holding Corporation's Committee on Uniform Securities Identification Procedures number is: 80706P103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site